JPS6350833A - Image forming method - Google Patents
Image forming methodInfo
- Publication number
- JPS6350833A JPS6350833A JP19674386A JP19674386A JPS6350833A JP S6350833 A JPS6350833 A JP S6350833A JP 19674386 A JP19674386 A JP 19674386A JP 19674386 A JP19674386 A JP 19674386A JP S6350833 A JPS6350833 A JP S6350833A
- Authority
- JP
- Japan
- Prior art keywords
- silver halide
- mol
- contg
- silver
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 18
- 229910052709 silver Inorganic materials 0.000 claims abstract description 29
- 239000004332 silver Substances 0.000 claims abstract description 29
- -1 silver halide Chemical class 0.000 claims abstract description 24
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 14
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000012545 processing Methods 0.000 claims abstract description 7
- 229910021607 Silver chloride Inorganic materials 0.000 claims abstract description 5
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims abstract description 5
- ORZRMRUXSPNQQL-UHFFFAOYSA-N 6-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2C=NNC2=C1 ORZRMRUXSPNQQL-UHFFFAOYSA-N 0.000 claims abstract description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 8
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 7
- 229940090898 Desensitizer Drugs 0.000 description 6
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229910052703 rhodium Inorganic materials 0.000 description 3
- 239000010948 rhodium Substances 0.000 description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 2
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- JCHQNLCHFONJGY-UHFFFAOYSA-N 2-hydroxy-2-phenyl-1-(2-sulfanylphenyl)ethanone Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1S JCHQNLCHFONJGY-UHFFFAOYSA-N 0.000 description 1
- OWIRCRREDNEXTA-UHFFFAOYSA-N 3-nitro-1h-indazole Chemical compound C1=CC=C2C([N+](=O)[O-])=NNC2=C1 OWIRCRREDNEXTA-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- MARUHZGHZWCEQU-UHFFFAOYSA-N 5-phenyl-2h-tetrazole Chemical compound C1=CC=CC=C1C1=NNN=N1 MARUHZGHZWCEQU-UHFFFAOYSA-N 0.000 description 1
- ZXQHSPWBYMLHLB-BXTVWIJMSA-M 6-ethoxy-1-methyl-2-[(e)-2-(3-nitrophenyl)ethenyl]quinolin-1-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC2=CC(OCC)=CC=C2[N+](C)=C1\C=C\C1=CC=CC([N+]([O-])=O)=C1 ZXQHSPWBYMLHLB-BXTVWIJMSA-M 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- ZUZQXHSOEZUAIS-UHFFFAOYSA-N nitric acid;6-nitro-1h-benzimidazole Chemical compound O[N+]([O-])=O.[O-][N+](=O)C1=CC=C2N=CNC2=C1 ZUZQXHSOEZUAIS-UHFFFAOYSA-N 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- 238000003969 polarography Methods 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
- G03C1/08—Sensitivity-increasing substances
- G03C1/09—Noble metals or mercury; Salts or compounds thereof; Sulfur, selenium or tellurium, or compounds thereof, e.g. for chemical sensitising
Abstract
Description
【発明の詳細な説明】
(A>産業上の利用分野
本発明は、画像形成方法に関するものであり、詳しくは
実質的に明室と呼ばれる条件の下で取り扱うことのでき
るハロゲン化銀写真感光材料を用いて印刷製版工程にお
いて優れた網点品質を持つ画像を得るための画像形成方
法に関する。Detailed Description of the Invention (A> Industrial Application Field The present invention relates to an image forming method, and more specifically to a silver halide photographic light-sensitive material that can be handled substantially under conditions called a bright room. This invention relates to an image forming method for obtaining an image with excellent halftone dot quality in a printing plate making process using a printing process.
(B)従来技術及びその問題点
近年、印刷分野においては、印刷物の複雑さ、スキャナ
ーの発達などにより、返し作業工程の能率向上が要望さ
れてきている。そのため従来から使用されてきた返し用
のフィルムに比べて10−3〜10−5程度の超低密度
の写真フィルムが開発され明室(紫外線を除いた白色蛍
光灯下)で取り扱いが可能な返しフィルム、即ち明室感
光材料として実用され始めてきた。(B) Prior art and its problems In recent years, in the printing field, due to the complexity of printed matter and the development of scanners, there has been a demand for improved efficiency in the turning process. For this reason, a photographic film with an ultra-low density of about 10-3 to 10-5 has been developed compared to the conventional film for return, which can be handled in a bright room (under white fluorescent light with no ultraviolet rays). It has begun to be put to practical use as a film, that is, a light-sensitive material.
このような明室感光材料に要求される性能は、硬調で十
分な最大濃度を有し、明室で長時間の取り扱いが可能で
あり、紫外光源に対しては高い感度を有していること等
でおる。しかし、これまでの明室用感光材料は上述した
ような性能を十分に満足しているとは言い難く、改良さ
れた明室用感光材料の開発が望まれている。The performance required of such bright room photosensitive materials is that they have high contrast and sufficient maximum density, can be handled for long periods of time in a bright room, and have high sensitivity to ultraviolet light sources. etc. However, it cannot be said that conventional photosensitive materials for use in bright rooms fully satisfy the above-mentioned performance, and there is a desire to develop improved photosensitive materials for use in bright rooms.
明室用感光材料のハロゲン化銀乳剤としては、特開昭5
6−125734号公報に記載されている如き塩化銀を
主体とするハロゲン化銀に無機減感剤として多口のロジ
ウムを使用する方法あるいは直接ポジ用ハロゲン化銀乳
剤で一般的に用いられるピナクリプトールイエローの如
き有機減感剤を使用する方法などによって製造される。As a silver halide emulsion for light-sensitive materials for bright room use, JP-A-5
6-125734, in which a large amount of rhodium is used as an inorganic desensitizer in silver halide mainly composed of silver chloride, or pinacryp, which is commonly used in direct positive silver halide emulsions. It is manufactured by a method using an organic desensitizer such as Tall Yellow.
ざらに特開昭59−177537に記載されているよう
に、明室下での長時間の安全性を向上させるために、2
−メルカプト安息香MX導体をハロゲン化銀もしくは乳
剤層の隣接層に添加することが知られている。As described in Japanese Patent Application Laid-open No. 59-177537, in order to improve long-term safety in a bright room,
- It is known to add mercaptobenzoin MX conductors to silver halide or adjacent layers of the emulsion layer.
一方、近年になって迅速かつ安定な処理で印刷製版工程
において必要な優れた網点品質を持つ銀画像を形成する
システムとして、ジヒドロキシベンゼン系現像工程と3
−ピラゾリドン系現像主楳:を組み合わせた現像液を用
いるシステム(ラピッドアクセスシステム)が実用化さ
れており、特開昭60−95538.58−19094
3等に記載されている。しかし、このシステムでは十分
に優れた網点品質を持つ銀画像を得ることは出来ない。On the other hand, in recent years, a dihydroxybenzene-based development process and three
- A system (Rapid Access System) using a developer in combination with: - Pyrazolidone-based developer has been put into practical use, and is published in Japanese Patent Application Laid-Open No. 60-95538.58-19094.
It is listed in 3rd class. However, with this system it is not possible to obtain a silver image with sufficiently excellent halftone quality.
(C)発明の目的
本発明の目的は、明室光下で安全に取り扱うことのでき
る明室用ハロゲン化銀写真感光材料を用いて迅速かつ安
定に優れた網点品質を持つ画像を与え得る画像形成方法
を提供することにある。(C) Object of the Invention The object of the present invention is to quickly and stably provide images with excellent halftone dot quality using a bright room silver halide photographic material that can be safely handled under bright room light. An object of the present invention is to provide an image forming method.
(D)発明の構成
本発明者は上記目的を達すべく鋭意研究を重ねた結果、
少なくとも80モル%の塩化銀を含むネガ型微粒子ハロ
ゲン化銀乳剤に、下記一般式〔I〕で表わされる化合物
を含んだハロゲン化銀写真感光材料を画像露光した後、
(1)ジヒドロキシベンゼン系現像主薬を0.05〜0
.5モル/I!含み、(2)補助現像主薬を実質的に含
有せず、(3)遊離の亜硫正イオンを0.25モル/l
以上含有し、(4)5−又は6−ニトロインダゾールを
20my/l以上含有し、(5)pHを10.5以上に
するに十分な罪のアルカリ剤を含有する現像液で処理す
ることによって上記目的が達成されることを見出した。(D) Structure of the invention As a result of extensive research to achieve the above objective, the inventor has
After imagewise exposing a silver halide photographic material containing a compound represented by the following general formula [I] to a negative fine-grain silver halide emulsion containing at least 80 mol% of silver chloride,
(1) Dihydroxybenzene-based developing agent from 0.05 to 0
.. 5 mol/I! (2) substantially free of auxiliary developing agents; (3) free positive sulfite ions of 0.25 mol/l
(4) containing 20 my/l or more of 5- or 6-nitroindazole, and (5) processing with a developer containing an alkaline agent sufficient to raise the pH to 10.5 or more. It has been found that the above objectives are achieved.
一般式CI)
(ここでR1とR2は同じ置換基でも、異なるものでも
良く、水素、ハロゲン原子、アルキル基、カルボキシル
基、アミノ基、アルコキシ基を示す。)以下これらの化
合物の具体例を示すが、本発明はこれらに限定されるも
のではない。General formula CI) (Here, R1 and R2 may be the same or different substituents, and represent hydrogen, a halogen atom, an alkyl group, a carboxyl group, an amino group, or an alkoxy group.) Specific examples of these compounds are shown below. However, the present invention is not limited thereto.
化合物1
l
13r Sr
化合物5
Br Cfl
CH3CH3
C2ト15 C2H5
″8
COOHCOOH
化合物9
COOHCz H5
“ 1O
N Hz N Hz
0CH30CH3
“ 12
Ct−f3
これらのジスルフィド化合物はハロゲン化銀乳剤中に添
加することが好ましいが、乳剤層の隣接層の塗液に添加
して乳剤層に拡散させても良い。Compound 1 l 13r Sr Compound 5 Br Cfl CH3CH3 C2to15 C2H5 ″8 COOHCOOH Compound 9 COOHCz H5 “ 1O N Hz N Hz 0CH30CH3 “ 12 Ct-f3 These disulfide compounds are silver halide milk It is preferable to add it to the agent. , it may be added to the coating solution of the layer adjacent to the emulsion layer and diffused into the emulsion layer.
添加時期は、乳剤製造工程の任意の時期でも良く、その
添加但は一般にハロゲン化銀1モル当り約20m3〜5
7の範囲で適宜選択するこができる。The addition period may be any time during the emulsion manufacturing process, and the addition period is generally about 20 m3 to 5 m3 per mole of silver halide.
It can be selected as appropriate within the range of 7.
本発明におけるハロゲン化銀乳剤は、一般に直接ポジ用
ハロゲン化銀乳剤用として知られている有機減感剤を含
むことができる。ここで言う有機減感剤は、そのポーラ
ログラフ半波電位、ポーラログラフイーで決定されるそ
の酸化還元電位によって特徴づけられる。すなわち、ポ
ーラログラフ陽極電位と陰極電位の和が正であるもので
ある。The silver halide emulsion in the present invention may contain an organic desensitizer generally known for use in direct positive silver halide emulsions. The organic desensitizer referred to herein is characterized by its polarographic half-wave potential, its redox potential determined by polarography. That is, the sum of the polarographic anode potential and the cathode potential is positive.
これらの酸化還元電位の測定法については、例えば米国
特許第3.50’l、307号明細書に記載されている
。Methods for measuring these redox potentials are described, for example, in US Pat. No. 3.50'1,307.
そのような有機減感剤の具体例は数多くの特許明細書、
文献に記載されており、それらはいずれも本発明におい
て同じ作用をもっているものであって、例えば特公昭3
6−’l 7595、開明39=20261、開明40
−26751、開明43−13167、開明45−88
33、開明47−8746、開明47−10197、開
明50−37530、特開昭48−24734、開明4
9−84639、開明56−142525、米国特許第
2.271.229号、同第2.541.472号、同
第3,035,917号、同第3,062.651号、
同第3.’124,458@、同第3.326,687
@、同第3,671,254号等の明細書に記載の化合
物が使用できる。Specific examples of such organic desensitizers can be found in numerous patent specifications,
All of them have the same effect in the present invention, and for example,
6-'l 7595, Kaimei 39=20261, Kaimei 40
-26751, Kaimei 43-13167, Kaimei 45-88
33, Kaimei 47-8746, Kaimei 47-10197, Kaimei 50-37530, JP-A-48-24734, Kaimei 4
9-84639, U.S. Pat. No. 56-142525, U.S. Patent No. 2.271.229, U.S. Pat.
Same 3rd. '124,458@, same number 3.326,687
Compounds described in specifications such as @ and No. 3,671,254 can be used.
本発明に用いられるハロゲン銀乳剤は、微粒子ハロゲン
化銀好ましくは平均粒径0.05μ〜0.3μ程度のも
のである。また、全粒子数の90%以上が平均粒径の±
10%範囲の粒径を有するものが好ましい。ハロゲン化
銀乳剤の調製方法は、順混合、逆混合、同時混合などの
公知の方法いずれでおってもよい。ロジウムは含有して
もしなくてもよい。The silver halide emulsion used in the present invention is a fine-grain silver halide emulsion, preferably having an average grain size of about 0.05 μm to 0.3 μm. In addition, more than 90% of the total number of particles is within ± the average particle size.
Those having a particle size in the 10% range are preferred. The silver halide emulsion may be prepared by any known method such as forward mixing, back mixing, and simultaneous mixing. Rhodium may or may not be included.
本発明より得られるハロゲン化銀乳剤は種々のカブリ防
止剤を含むことができる。一般的にはべンゾトリアゾー
ル、1−フェニル−5−メルカプトテトラゾールである
。The silver halide emulsion obtained according to the present invention can contain various antifoggants. Generally it is benzotriazole, 1-phenyl-5-mercaptotetrazole.
本発明より得られるハロゲン化銀乳剤は、カバリングパ
ワー向上剤、イラジェーション防止剤、膜物性改良剤、
界面活性剤、硬膜剤、マット剤、現像主薬等々の一般の
写真用乳剤に用いられる添加剤を含むことができ、公知
の支持体上に塗布される。保護層、下塗層などの他の親
水性コロイド層を有していても良い。The silver halide emulsion obtained by the present invention contains a covering power improver, an irradiation inhibitor, a film property improver,
It can contain additives used in general photographic emulsions such as surfactants, hardeners, matting agents, developing agents, etc., and is coated on a known support. It may have other hydrophilic colloid layers such as a protective layer and an undercoat layer.
本発明により得られる明掌用感光材料は主として印刷分
野で用いられる紫外光に富んだ光源、例えば水銀灯、超
高圧水銀灯、メタルハライド等により露光される。The light-sensitive photosensitive material obtained according to the present invention is exposed to light using a light source rich in ultraviolet light mainly used in the printing field, such as a mercury lamp, an ultra-high pressure mercury lamp, a metal halide, and the like.
本発明にあける水性アルカリ現像液は、(1)ジヒドロ
キシベンゼン系現像主薬を0.05〜0.5モル/l含
み、(2)補助現像主薬を実質的に含有せず、(3)遊
離の亜硫酸イオンを0.25モル/り以上含有し、(4
)5−又は6−ニトロインダゾールを20m’J/I!
以上含有し、(5)pHを10.5以上にするに十分な
量のアルカリ剤を含有する。The aqueous alkaline developer used in the present invention (1) contains 0.05 to 0.5 mol/l of a dihydroxybenzene-based developing agent, (2) contains substantially no auxiliary developing agent, and (3) contains free Contains 0.25 mol/liter or more of sulfite ions, (4
) 5- or 6-nitroindazole at 20 m'J/I!
and (5) contains an alkaline agent in an amount sufficient to adjust the pH to 10.5 or higher.
ジヒドロキシベンゼン系現像主薬としては、例えばハイ
ドロキノン、クロロハイドロキノン、ブロモハイドロキ
ノン、イソプロピルハイドロキノン、トルヒドロハイド
ロキノン、メチルハイドロキノン、2,3−ジクロロハ
イドロキノン、2,5ジメチルハイドロキノン等がある
。Examples of dihydroxybenzene-based developing agents include hydroquinone, chlorohydroquinone, bromohydroquinone, isopropylhydroquinone, toluhydrohydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, and 2,5 dimethylhydroquinone.
本発明における水性アルカリ現像液は空気酸化から現像
剤を保古する目的で、亜硫酸保恒剤を含有している。The aqueous alkaline developer in the present invention contains a sulfite preservative for the purpose of preserving the developer from air oxidation.
例えば、亜硫酸ナトリウム、亜硫酸カリウム、メタ重亜
硫酸カリウム、重亜硫酸ナトリウム等が添加される。好
ましい添加量は0.25〜1.00モル/!である。For example, sodium sulfite, potassium sulfite, potassium metabisulfite, sodium bisulfite, etc. are added. The preferred amount added is 0.25 to 1.00 mol/! It is.
本発明における水性アルカリ現像液は、5−おるいは6
−ニトロインダゾールを含む。好ましい添加量は20m
g/I!以上である。The aqueous alkaline developer in the present invention is 5- or 6-
- Contains nitroindazole. The preferred addition amount is 20m
g/I! That's all.
本発明における水性アルカリ現像液は、D +−(’2
調整するための水酸化カリウム、水酸化ナトリウム、炭
酸カリウム、炭酸ナトリウム、酢酸ナトリウム、第三リ
ン酸カリウム等を含む。The aqueous alkaline developer in the present invention has D+-('2
Contains potassium hydroxide, sodium hydroxide, potassium carbonate, sodium carbonate, sodium acetate, potassium triphosphate, etc. for adjustment.
好ましいpHは10.5以上である。The preferred pH is 10.5 or higher.
本発明における水性アルカリ現像液は、カブリの生成を
最小限度に抑えるために、また好ましい写真特性を1q
る目的で、必要な有機カブリ防止剤を含む。ベンゾトリ
アゾール、6−ニトロベンズイミダゾール硝酸塩、5−
メチルベンゾl−リアゾール、1−フェニル−2−テト
ラゾリン−5−チオン、5−フェニルテトラゾール、1
−フェニル−5−メルカプトテトラゾール等が一般的で
あり、好ましくは5−メチルベンゾトリアゾールである
。The aqueous alkaline developer in the present invention is used to minimize fog formation and to provide desirable photographic properties by 1q.
Contains necessary organic antifoggants for the purpose of Benzotriazole, 6-nitrobenzimidazole nitrate, 5-
Methylbenzo l-lyazole, 1-phenyl-2-tetrazoline-5-thione, 5-phenyltetrazole, 1
-Phenyl-5-mercaptotetrazole and the like are common, and 5-methylbenzotriazole is preferred.
本発明における水性アルカリ現像液はアスコルビン酸、
ジェタノールアミン、コウジ酸等の酸化防止剤、ニトリ
ロトリ酢酸、エヂレンジアミンテトラ酢酸等の硬水軟化
剤、ポリアルキレンオキサイド類、アミノ化合物、トリ
エチレングリコール、メタノール等の有職溶剤を含むこ
とが出来る。The aqueous alkaline developer in the present invention includes ascorbic acid,
It can contain antioxidants such as jetanolamine and kojic acid, water softeners such as nitrilotriacetic acid and ethylenediaminetetraacetic acid, polyalkylene oxides, amino compounds, triethylene glycol, methanol and the like.
本発明にあける画像形成方法は、印刷工程で必要な優れ
た網点品質を持つ銀画像を迅速に得ることを可能にし、
かつ、艮明間安定な使用が可能になるという利点を持つ
。The image forming method of the present invention makes it possible to quickly obtain a silver image with excellent halftone dot quality required in the printing process,
Moreover, it has the advantage that it can be used stably for a long period of time.
(E)実施例
実施例1
塩化銀95モル%を含む塩臭化銀1モル当り、アデニン
を100mg及びロジウムを10−5モル使用して通常
の方法でハロゲン化銀の沈澱を行い、物理熟成を施して
平均粒径0.1譚で粒度分布の狭い乳剤を19だ。この
乳剤を脱塩し、再溶解した後に有機減感剤としてピナク
リプトール・イエローを、ハロゲン化銀1モル当り50
0mg、更に硬膜剤、界面活性剤を加えてポリエステル
フィルム上に銀として3.59/尻となるように保護層
用ゼラチン液と共に塗布し、乾燥した(ブランク試料)
。(E) Examples Example 1 Silver halide was precipitated in a conventional manner using 100 mg of adenine and 10 −5 mol of rhodium per 1 mol of silver chlorobromide containing 95 mol % of silver chloride, followed by physical ripening. 19 to produce an emulsion with an average grain size of 0.1 mm and a narrow grain size distribution. After desalting and redissolving this emulsion, Pinacryptol Yellow was added as an organic desensitizer at a concentration of 50% per mole of silver halide.
0 mg, further added a hardening agent and a surfactant, and coated on a polyester film with a gelatin solution for a protective layer so that the silver ratio was 3.59/edge, and dried (blank sample).
.
これを試料Aとする。This is designated as sample A.
ざらに上記の乳剤に一般式(1)で例示された化合物(
1)をui1モル当り50mg加え、同様にフィルムに
塗布し、乾燥した。これを試料Bとする。Roughly, the above emulsion contains a compound exemplified by general formula (1) (
1) was added in an amount of 50 mg per 1 mole of ui, coated on a film in the same manner, and dried. This is designated as sample B.
試料A及び試料Bを明至プリンターを用いてセンシトメ
トリーを行い、表−1に示される二種類の現像液を用い
て、38度20秒の条件で処理を行い、定着、乾燥した
。Samples A and B were subjected to sensitometry using a Meishi printer, processed using two types of developing solutions shown in Table 1 at 38 degrees Celsius for 20 seconds, fixed, and dried.
表−1現像液処方
表−1において処理液Bは本発明における現像液、処理
液Aは、本発明から5−ニトロインダゾールを除いたも
のである。Table 1 Developer Formula In Table 1, Processing Solution B is the developer of the present invention, and Processing Solution A is the developer of the present invention except for 5-nitroindazole.
評価結果を表2に示す。The evaluation results are shown in Table 2.
表−2中、網点品質は5段階の数字で表わされ、5が最
良である。この表から、本発明における感光材料と処理
液を組み合わせた時のみ、高品質の網点が得られること
がわかる。In Table 2, the halftone dot quality is expressed in five levels, with 5 being the best. From this table, it can be seen that high quality halftone dots can be obtained only when the photosensitive material of the present invention and the processing liquid are combined.
従って本発明の画像形成方法が印刷工程で必要な優れた
網点品質を1qる上で、極めて有用であることがわかる
。Therefore, it can be seen that the image forming method of the present invention is extremely useful in achieving the excellent halftone dot quality required in the printing process.
実施例2
実施例1と同様の方法で乳剤を調整し、さらに、一般式
〔I〕で例示した化合物(1)〜(12)を銀1モル当
り50m’jずつ加え、フィルムに塗布し、乾燥したく
フィルム1〜12)。12種のフィルムを明室プリンタ
ーを用いてセンシトメトリーを行い、処理液Bを用いて
38°C20秒間現像を行い、定着、乾燥した。その時
の結果を表−3に示す。Example 2 An emulsion was prepared in the same manner as in Example 1, and further, compounds (1) to (12) exemplified by general formula [I] were added in an amount of 50 m'j per mole of silver, and applied to a film. Dry film 1-12). Twelve types of films were subjected to sensitometry using a bright room printer, developed using processing solution B at 38°C for 20 seconds, fixed, and dried. The results are shown in Table 3.
(以下余白)
表−3
この表から、本発明における化合物及び画像形成方法は
、安定な現像液を用いて優れた網点品質を得るための極
めて有用な方法であると言える。(The following is a blank space) Table 3 From this table, it can be said that the compound and image forming method of the present invention are extremely useful methods for obtaining excellent halftone dot quality using a stable developer.
Claims (5)
子ハロゲン化銀写真乳剤に下記一般式〔 I 〕で表わさ
れる化合物を含むハロゲン化銀写真感光材料を画像露光
した後(1)ジヒドロキシベンゼン系現像主薬を0.0
5〜0.5モル/l含み、(1) After imagewise exposing a silver halide photographic light-sensitive material containing a compound represented by the following general formula [I] to a negative fine-grain silver halide photographic emulsion containing at least 80 mol % of silver chloride, (1) dihydroxybenzene-based 0.0 developing agent
Contains 5 to 0.5 mol/l,
し、(3) Contains 0.25 mol/l or more of free sulfite ions,
以上含有し、(4) 20 mg/l of 5- or 6-nitroindazole
Contains more than
剤を含有する現像液で処理することを特徴とする画像形
成方法。 一般式〔 I 〕 ▲数式、化学式、表等があります▼ (ここでR_1とR_2は同じ置換基でも、異なるもの
でもよく、水素、ハロゲン原子、アルキル基、カルボキ
シル基、アミノ基、アルコキシ基を示す。)(5) An image forming method characterized by processing with a developer containing an alkaline agent in an amount sufficient to adjust the pH to 10.5 or higher. General formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (Here, R_1 and R_2 may be the same or different substituents, and represent hydrogen, halogen atom, alkyl group, carboxyl group, amino group, or alkoxy group. .)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19674386A JPS6350833A (en) | 1986-08-21 | 1986-08-21 | Image forming method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19674386A JPS6350833A (en) | 1986-08-21 | 1986-08-21 | Image forming method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6350833A true JPS6350833A (en) | 1988-03-03 |
Family
ID=16362864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19674386A Pending JPS6350833A (en) | 1986-08-21 | 1986-08-21 | Image forming method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6350833A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01161341A (en) * | 1987-12-18 | 1989-06-26 | Fuji Photo Film Co Ltd | Developing method for silver halide photographic sensitive material |
US5418127A (en) * | 1993-05-28 | 1995-05-23 | Eastman Kodak Company | Water-soluble disulfides in silver halide emulsions |
JP4955884B2 (en) * | 2000-01-31 | 2012-06-20 | ジェオックス エス.ピー.エー. | Clothing with vents |
-
1986
- 1986-08-21 JP JP19674386A patent/JPS6350833A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01161341A (en) * | 1987-12-18 | 1989-06-26 | Fuji Photo Film Co Ltd | Developing method for silver halide photographic sensitive material |
US5418127A (en) * | 1993-05-28 | 1995-05-23 | Eastman Kodak Company | Water-soluble disulfides in silver halide emulsions |
JP4955884B2 (en) * | 2000-01-31 | 2012-06-20 | ジェオックス エス.ピー.エー. | Clothing with vents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4172728A (en) | High contrast continuous tone developer and process of use | |
JPS60123837A (en) | Photographic silver halide emulsion | |
US4455365A (en) | Silver halide photographic material for photomechanical process and reduction processing method thereof | |
JPS6350833A (en) | Image forming method | |
JP3240334B2 (en) | Method for developing black-and-white silver halide photographic materials | |
US3161513A (en) | Photographic developer compositions containing an antistain agent | |
JPH0311455B2 (en) | ||
JPH10198002A (en) | Black-and-white development processing method | |
JPS6350834A (en) | Image forming method | |
EP0690343B1 (en) | Photographic silver halide developer composition and process for forming photographic silver images | |
US5478706A (en) | Alkaline black-and-white developer for silver halide photographic material | |
US5589323A (en) | Chemically stable ascorbate-based photographic developer and imaging process | |
JPS63136043A (en) | Method for processing silver halide photographic sensitive material | |
US5968720A (en) | Photographic fixer compositions and method for processing a photographic element | |
EP0654148B1 (en) | Use of ketogluconates in photography | |
JPH0343609B2 (en) | ||
JPH01229248A (en) | Method for processing silver halide photosensitive material | |
JP2002229161A (en) | Black-and-white developing composition and its use method | |
JP2593260B2 (en) | Silver halide photographic material | |
JP3372423B2 (en) | Developing processing method of silver halide black and white photographic paper | |
JPH02254438A (en) | Processing method for silver halide photographic sensitive material | |
JPH07168323A (en) | Method for developing silver halide photographic sensitive material | |
EP0329335A2 (en) | Pattern free lithographic elements | |
JPH08220719A (en) | Method for stabilizing silver image | |
JPH08220718A (en) | Method for stabilizing silver image |